Position in SCLX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$59
-$136 QoQ
Shares Held
14
-46.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in SCLX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MAI Capital Management holds $587,268,758 across 14 Drug Manufacturers - General names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
616,940 | $155,246,781 | |
| 2 | LLY |
ELI LILLY & Co
|
127,320 | $152,711,440 | |
| 3 | JNJ |
Johnson & Johnson
|
548,420 | $139,282,227 | |
| 4 | MRK |
Merck & Co., Inc.
|
380,217 | $48,857,884 | |
| 5 | AMGN |
Amgen Inc
|
100,869 | $36,526,682 | |
| 6 | PFE |
Pfizer Inc
|
614,061 | $14,786,588 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
247,151 | $14,240,840 | |
| 8 | NVS |
Novartis AG
|
43,150 | $6,762,467 |
All Filings in SCLX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $59 | 9 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $195 | 16 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $354 | 18 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $106 | 18 | Shares | Sole | 2025-08-12 | |
| No filing history on record for this holder in this stock. | ||||||